The CNNM3 Polyclonal Antibody is a powerful research reagent designed to target CNNM3 (Cyclin M3), a protein involved in magnesium transport and homeostasis. CNNM3 plays a critical role in cellular metabolism, ion transport, and has been implicated in various pathological processes, including cancer progression and metastasis. This antibody is widely used in molecular biology, biochemistry, and medical research to study the expression, localization, and function of CNNM3.
Overview of CNNM3
Key Features of CNNM3:
- Full Name: Cyclin M3 (CNNM3).
- Primary Function: Regulates magnesium transport across membranes and contributes to maintaining intracellular magnesium levels.
- Tissue Distribution: Expressed in various tissues, including the kidney, brain, and certain cancer types.
- Role in Cancer: Altered CNNM3 expression has been linked to tumor progression, making it a potential biomarker and therapeutic target in oncology.
For more information on CNNM3, visit UniProt or NCBI.
Features of the CNNM3 Polyclonal Antibody
- High Specificity:
- Designed to specifically recognize endogenous CNNM3 protein with minimal cross-reactivity.
- Broad Applicability:
- Suitable for various techniques, including:
- Western Blot (WB): Detects CNNM3 protein in cell and tissue lysates.
- Immunohistochemistry (IHC): Visualizes CNNM3 expression in tissue samples.
- Immunofluorescence (IF): Studies CNNM3 localization in cells.
- Suitable for various techniques, including:
- Species Reactivity:
- Validated for use in human, mouse, and rat samples.
- Quality Control:
- Rigorous testing ensures consistent performance and reliable results.
Applications in Research
- Magnesium Transport Studies:
- Investigates CNNM3’s role in maintaining magnesium homeostasis.
- Cancer Research:
- Explores the link between CNNM3 expression and tumor progression or metastasis.
- Neurobiology:
- Studies CNNM3’s function in magnesium regulation in neural tissues.
- Drug Development:
- Evaluates CNNM3 as a potential therapeutic target for cancer and metabolic disorders.
Protocols for CNNM3 Polyclonal Antibody Use
Western Blot (WB):
- Sample Preparation:
- Lyse cells or tissues and quantify protein concentration.
- Electrophoresis:
- Separate proteins on an SDS-PAGE gel and transfer them to a membrane.
- Antibody Incubation:
- Dilute the CNNM3 antibody (1:1000–1:5000 recommended).
- Incubate overnight at 4°C.
- Detection:
- Use an HRP-conjugated secondary antibody and chemiluminescent substrate.
Immunohistochemistry (IHC):
- Tissue Preparation:
- Fix tissues in formalin and embed them in paraffin.
- Perform antigen retrieval.
- Antibody Incubation:
- Dilute the CNNM3 antibody (1:200–1:1000 recommended) and apply to tissue sections.
- Visualization:
- Use a suitable detection system and counterstain.
Benefits of Using CNNM3 Polyclonal Antibody
- High Sensitivity and Specificity:
- Ensures accurate detection of CNNM3 protein in diverse applications.
- Versatility:
- Compatible with multiple experimental platforms.
- Reproducibility:
- Consistent performance across experiments.
- Cost-Effective:
- A reliable alternative to monoclonal antibodies for various research needs.
Challenges and Future Directions
Challenges:
- Optimization: Requires careful optimization of antibody dilution and protocol conditions.
- Cross-Reactivity: Potential for off-target binding in certain samples.
Future Innovations:
- Multiplex Antibody Panels:
- Develop combinations of antibodies for comprehensive ion transport studies.
- Therapeutic Applications:
- Utilize CNNM3 as a drug target in cancer and metabolic research.
Conclusion
The CNNM3 Polyclonal Antibody is an invaluable tool for researchers investigating magnesium transport, cellular metabolism, and cancer biology. Its high specificity, broad applicability, and robust performance make it a critical reagent for advancing understanding in these fields.
For further resources and technical support, visit: